`
`
`
`Paper No. 11
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`
`
`OPUS KSD INC.,
`Petitioner
`
`v.
`
`INCISIVE SURGICAL, INC.,
`Patent Owner
`
`
`______________
`
`IPR2017-01438
`Patent 8,821,517
`______________
`
`
`
`PATENT OWNER OPPOSITION
`TO PETITIONER MOTION
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`TABLE OF CONTENTS
`
`TABLE OF AUTHORITIES ................................................................................... iii
`
`EXHIBIT LIST .......................................................................................................... v
`
`I. INTRODUCTION ................................................................................................. 1
`
`II. ARGUMENT ....................................................................................................... 1
`A. The Motion Fails to Carry Its Burden of Proof .................................................. 1
`B. SOFs Are Not Requests for Admission .............................................................. 2
`C. Patentee’s Responses to the SOF Comply With Rule 42.23(a) .......................... 3
`D. The Board Has No Authority to Grant Equitable Relief .................................... 5
`
`CONCLUSION .......................................................................................................... 5
`
`
`
`
`
`
`
`
`
`ii
`
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
` TABLE OF AUTHORITIES
`
`IPR2017-01438
`
`
`Statutes
`
`35 U.S.C. §253(a) ..................................................................................................... 2
`
`Regulations
`
`37 CFR §42.11 .......................................................................................................... 5
`
`37 CFR §42.11(c)(2) ................................................................................................. 5
`
`37 CFR §42.12 .......................................................................................................... 5
`
`37 CFR §42.20(c) ...................................................................................................... 1
`
`37 CFR §42.22 .......................................................................................................... 2
`
`37 CFR §42.22(c) ...................................................................................................... 3
`
`37 CFR §42.23 .......................................................................................................... 2
`
`37 CFR §42.23(a) ...................................................................................................... 3
`
`37 CFR §42.24 .......................................................................................................... 2
`
`37 CFR §42.51(a) ...................................................................................................... 2
`
`37 CFR §42.51(b) ..................................................................................................... 2
`
`Cases
`Commissioner v. McCoy, 484 U.S. 3 (1987). ............................................................ 5
`
`Guinn v. Kopf, 96 F.2d 1419 (Fed. Cir. 1996) .......................................................1, 2
`
`
`
`iii
`
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
`IPR2017-01438
`
`Koninklijke Philips Electronics N.V. v. Cardiac Science Operating Co., 590 F.3d
`1326 (Fed.Cir. 2010) .............................................................................................. 4
`
` Paper 11
`
`Richardson v. Morris, 409 U.S. 464 (1973). ............................................................. 5
`
`Other Authorities
`
`FRCP 36(a)(4) ............................................................................................................ 2
`
`77 Fed.Reg. 48756 (Aug. 14, 2012) . ........................................................................ 3
`
`77 Fed.Reg. 48612 (Aug. 14, 2012) . ........................................................................ 3
`
`Apple, Inc. v. Achates Reference Publishing, Inc., IPR2013-00081 (PTAB, Mar.
`27, 2013) (Paper 21 – Decision to Institute) .......................................................... 3
`
`
`
`
`
`
`
`
`
`iv
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`EXHIBIT LIST
`
`Ex.1001 – U.S. Patent No. 8,821,517 (’517 Patent).
`
`Ex.1002 – Declaration of Charles Rogers, Phd.
`
`Ex.1003 – U.S. Publication 2012/0325889 (’889 Publication).
`
`Ex.1004 – Claims From Application No.13/796,798 (’798 Application).
`
`Ex.1005 – Excerpt From ’517 Patent File History.
`
`Ex.1006 – U.S. Patent No. 5,489,287 (‘287 Patent or Green).
`
`Ex.1007 – Photos of Petitioner’s Stapler.
`
`Ex.1008 – Excerpt From ‘200 [sic] Patent File History.
`
`Ex.1009 – Letter from Patent Owner to Petitioner.
`
`Ex.1010 – Photo of Commercial Patent Owner’s Commercial Stapler.
`
`Ex.1011 – Photo of Commercial Patent Owner’s Commercial Stapler.
`
`Ex.1012 – Declaration of Peter Stokes.
`
`Ex.1013 – Principles of Wound Management.
`
`Ex.1014 – Pediatric Emergency Procedures.
`
`Ex.1015 – Ethicon Wound Closure Manual.
`
`Ex.1016 – U.S. Patent No. 3,716,058.
`
`Ex.1017 – Declaration of H. V. Mendenhall, DVM, Phd.
`
`Ex.1018 – Excerpt from ‘838 Application.
`
`. . .
`
`
`
`v
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`Ex.2001 – Statutory Disclaimer.
`
`Ex.2002 – Response to the “Amendments to the Rules of Practice for Trials
`
`Before the Patent Trial and Appeal Board,” Fed. Reg. Vol. 80, No. 161 (August 20,
`
`2015) (November 18, 2015) (available at
`
`https://www.uspto.gov/sites/default/files/documents/PTAB%20Rules%20Aug%20
`
`2015%20Individual%20Smith%20Pedersen%20Comments.pdf)
`
`Ex. 2003 - Excerpt from Application No. 13/604,190 (Petitioner application
`
`associated with '889 Publication).
`
`Ex. 2004 - Excerpts from Application No. 15/145,194 (Patentee application
`
`associated with '472 Patent).
`
`Ex. 2005 - Excerpts from Application No. 13/796,798 (Patentee application
`
`associated with '517 Patent).
`
`
`
`
`
`
`
`vi
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`ABBREVIATIONS AND DEFINITIONS
`
`Patentee – Incisive Surgical, Inc.
`
`Petitioner – Opus KSD Inc.
`
`‘517 Patent – U.S. Patent No. 8,821,517.
`
`‘889 Publication – U.S. Publication 2012/0325889.
`
`‘190 Application – U.S. Application 13/604,190 associated with ’889 Publication
`
`‘798 Application – U.S. Application No.13/796,798.
`
`‘472 Patent – U.S. Patent No. 9,717,472.
`
`‘550 Publication – U.S. Publication 2003/0236550
`
`‘705 Patent – U.S. Patent No. 6,726,705 assocated with ’550 Publication
`
`Board – the United States Patent Trial and Appeal Board.
`
`PTO – the United States Patent and Trademark Office.
`
`
`
`vii
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`I. INTRODUCTION
`
`Petitioner’s Motion to Deem Material Facts Admitted should be denied for
`
`multiple reasons. First, the Motion fails to prove that the the Board has the
`
`authority to grant the relief requested. Once the statutory disclaimer was filed by
`
`Patentee, it is as if the specific disclaimed claims of the ‘517 Patent never existed.
`
`Guinn v. Kopf, 96 F.2d 1419 (Fed. Cir. 1996). The Motion fails to address how the
`
`Board has any authority to grant the relief requested for claims that never existed.
`
`Second, the proposed Statement of Material Facts (SOF) are not, as Petitioner
`
`contends, requests for admission. Accordingly, the rules and obligations under the
`
`FRCP are irrelevant. Third, Petitioner’s SOF do not comply with the SOF rules,
`
`whereas Patentee has properly responded to each SOF under the rules.
`
`Consequently, there is no reason for the Board to alter Patentee’s SOF responses.
`
`Finally, the Board has no statutory or regulatory authority to provide what is an
`
`equitable relief urged by Petitioner.
`
`II. ARGUMENT
`
`A. The Motion Fails to Carry Its Burden of Proof
`
`Under 37 C.F.R. §42.20(c), Petitioner has “the burden of proof to establish
`
`that it is entitled to the requested relief.” The Motion argues that the Board has the
`
`statutory authority to consider the petition. (Paper 8, p.4-5). The Motion, however,
`
`never explains or cites any authority or even other Board panel decisions as to how
`
`
`
`1
`
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
`IPR2017-01438
`
`the Board has authority to consider the Motion, as opposed to a petition, and to
`
` Paper 11
`
`grant the extraordinary relief of deeming the proposed SOF to be admitted that is
`
`requested by the Motion. Nor does the Motion carry its burden to explain why the
`
`Board has jurisdiction and authority to grant any relief once a statutory disclaimer
`
`has been filed. The case law regarding a statutory disclaimer make clear that:
`
` A statutory disclaimer under 35 U.S.C. §253(a) has the effect of
`cancelling the claims from the patent and the patent is viewed as
`though the disclaimed claims had never existed in the patent.
`Guinn at 1422.
`
`
`
`Given that the claims of the ‘517 Patent are as if they never existed, it is up
`
`to Petitioner to prove both that the Board has the authority to grant such
`
`extraordinary relief and how such relief can be awarded if the claims never existed.
`
`B. SOFs Are Not Requests for Admission
`
`Without citing any authority, the Motion argues that FRCP 36(a)(4) is
`
`somehow relevant to the Rules relating to SOFs under 37 C.F.R. §§42.22–42.24,
`
`and that Patentee somehow has an obligation to explain its responses to the
`
`proposed SOFs. (Paper 8, p.1-4). Petitioner is mistaken. Rule 42.51(b) makes clear
`
`that a party “is not entitled to discovery” other than mandatory discovery pursuant
`
`to Rule 42.51(a) or discovery authorized by motion or agreed upon by the parties.
`
`Likewise the Trial Practice Guidelines confirm that the types of discovery
`
`available under the FRCP can be sought, but only by requesting and filing a motion
`
`
`
`2
`
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
`IPR2017-01438
`
`for such discovery. 77 Fed.Reg. 48756, 48761 (Aug. 14, 2012). Petitioner made
`
` Paper 11
`
`no such motion for requests for admission. Nor is anything in the Rules or
`
`Guidelines that imposes an obligation on a party to explain any responses to
`
`proposed SOF. There are only a few panel decisions that even address the use of
`
`lists of SOF under Rule 42.22(c) in a petition or motion, and most are focused on
`
`how the listing of SOF are measured against page and word count limits. In terms
`
`of whether SOFs should be deemed admitted, the only relevant decision Patentee
`
`could find was Apple, Inc. v. Achates Reference Publishing, Inc., IPR2013-00081,
`
`slip op. at 20 (PTAB, Mar. 27, 2013) (Paper 21 – Decision to Institute) (“we do not
`
`deem any facts denied by Patent Owner as admitted for this proceeding . . .”).
`
`C. Patentee’s Responses to the SOF Comply With Rule 42.23(a)
`
`All of Patentee’s Responses comply with Rule 42.23(a) because each
`
`response includes one of the three permitted responses – “admitted, denied or
`
`cannot be admitted or denied.” As evidenced by the comments on the rules, the
`
`final sentence of Rule 42.23(a) is inapplicable here because it relates only to a
`
`situation where a list of proposed SOFs are completely ignored. 77 Fed.Reg.
`
`48612, 48633 (Aug. 12, 2012) (Comment 80).
`
`Petitioner’s failure to comply with Rule 42.22(c) by not identifying in the
`
`record the source for the proposed SOF and failure to properly define terminology
`
`used in the proposed SOF are partly responsible for Patentee having to respond that
`
`
`
`3
`
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
`IPR2017-01438
`
`a proposed SOF “cannot be admitted or denied.” For example, the term “‘889
`
` Paper 11
`
`Publication” is undefined for SOFs 11-12. SOFs 9 and 10 are unanswerable
`
`because the statements about the priority chain of the ‘517 Patent are split between
`
`two separate SOFs, neither of which alone is accurate. For SOFs 5 and 8, the
`
`proposed statements are not statements of fact; rather, these statements use
`
`undefined terminology such as “copied” or “developed or disclosed” that
`
`necessarily call for a legal conclusion. See, Koninklijke Philips Electronics N.V. v.
`
`Cardiac Science Operating Co., 590 F.3d 1326, 1335-36 (Fed.Cir. 2010).
`
`Accordingly, these statements are not proper for a proposed SOF.
`
`For SOFs 6-7, although the Motion cites to the record for SOFs 6-7 (Paper 8,
`
`p.3-4), these citations were not part of the proposed SOFs in the Petition. Even
`
`though there is no basis for requiring Patentee to explain its denial of SOFs 6-7,
`
`Patentee notes that the PTO has thrice determined that the claimed subject matter
`
`was “presented” as being described and enabled in the priority applications for the
`
`‘517 Patent. (Ex. 2003, pp. 4-7, Ex.2004, pp. 4-9 & 18, Ex.2005, pp. 2-6). Not only
`
`is there no requirement for Patentee to explain its response to SOF 6-7, there is no
`
`authority for the Board to change Patentee’s responses to SOFs 6-7. Likewise,
`
`there is no reason for the Board to alter any of the other of Patentee’s SOF
`
`responses.
`
`
`
`4
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`D. The Board Has No Authority to Grant Equitable Relief
`
`As an Article I tribunal, the Board’s authority is expressly limited to what is
`
`provided by statute and does not include the authority to consider equitable
`
`principles unless authorized by statute. See, e.g., Richardson v. Morris, 409 U.S.
`
`464, 465 (1973); Commissioner v. McCoy, 484 U.S. 3, 7 (1987).
`
`Although the Board has the authority to impose sanctions under 37 C.F.R.
`
`§§42.11–42.12, these rules are never argued in the Motion. Rule 42.11(c)(2) makes
`
`clear that any motion for sanctions “must be made separately from any other
`
`motion.” For all of the reasons set forth in this Opposition and Petitioner’s Sur-
`
`Reply (Paper 10), there is simply no basis for alleging that Patentee has breached
`
`any duty of candor or good faith to the Office or is not otherwise in compliance
`
`with the certification requirements so as to merit any motion for sanctions.
`
`Here, the Motion argues in equity for the Board to deem admitted proposed
`
`SOF 5-12, including SOFs 6-7 that were expressly denied. Patentee has fully
`
`complied with the rules regarding proposed SOFs, and the Motion sets forth no
`
`basis in statute or regulation for the Board to award the extraordinary relief that is
`
`requested. Because the Board does not have any inherent authority to provide relief
`
`in equity and there is nothing to merit it, the Motion must therefore be denied.
`
`CONCLUSION
`
`Patentee respectfully requests that the Board deny the Motion.
`
`
`
`5
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`
`
`
`
`Dated: September 12, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
` s/Brad D. Pedersen
`Brad D. Pedersen
`Reg. No. 32,432
`Patterson, Thuente, Pedersen P.A.
`4800 IDS Center
`80 South 8th Street
`Minneapolis, MN 55402
`pedersen@ptslaw.com
`Telephone: (612) 349-5774
`Facsimile: (612) 349-9266
`Attorneys for Patent Owner,
`Incisive Surgical, Inc.
`
`
`
`
`
`
`6
`
`
`
`IPR2017-01438
`
`
`INTER PARTES REVIEW OF US PATENT NO. 8,821,517
`
` Paper 11
`
`CERTIFICATE OF SERVICE
`
`
`
`Pursuant to 37 C.F.R. §§42.6(e)(4)(i) et seq., the undersigned certifies that
`
`on September 12, 2017, a complete and entire copy of this PATENT OWNER
`
`OPPOSITION TO PETITIONER MOTION for Inter Partes Review of U.S.
`
`Patent 8,821,517 and supporting materials was provided via electronic service by
`
`e-mail to:
`
`Vincent E. McGeary
`vmcgeary@mcgearycukor.com
`7 Dumont Place
`Morristown NJ 07960
`
`
`
`
`
`
`
`
`
`
` /Brad D. Pedersen/
`Brad D. Pedersen
`Reg. No. 32,432
`Attorney for Petitioner
`
`
`Dated: September 12, 2017
`
`
`
`
`
`
`
`
`
`
`7
`
`